Journal profile · Biochemistry & Molecular Biology
Folia Histochemica et Cytobiologica
ISSN 0239-8508 · eISSN 1897-5631 · Via Medica · POLAND · Quarterly · Founded 1984
Folia Histochemica et Cytobiologica: CAS Zone 4 · Biology (2025 upgraded edition); impact factor 1.8; fully open access; APC charged, amount not published; median 69 days to acceptance (35 articles, last 24 months); community-reported acceptance: easy; 20 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Folia Histochemica et Cytobiologica is published by Via Medica and is in Zone 4 of Biology in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Protease and Inhibitor Mechanisms, Sperm and Testicular Function and Regulation of Appetite and Obesity, together about 18% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Folia Histochemica et Cytobiologica publishes peer-reviewed articles in histochemistry, cytochemistry, histology, cell biology, tissue biology, and cellular pathology. The journal covers experimental and translational research on the structure, function, molecular organization, and pathological alterations of cells and tissues in normal and disease conditions. Its scope includes molecular and functional morphology, cell and tissue architecture, immunohistochemistry, immunocytochemistry, molecular pathology, biomarker studies, microscopy and imaging methods, and disease mechanisms at the cellular and tissue level. The journal also welcomes studies on cell signaling, proliferation, differentiation, apoptosis, senescence, oxidative stress, inflammation, oncogenesis, carcinogenesis, and regenerative or experimental cell and tissue models, provided that the primary focus remains on histochemical, cytochemical, cellular, or tissue-based research. Interdisciplinary submissions from biomedical, medical, veterinary, and biological sciences are considered when they fall within the journal’s core scope.
From the journal's Aims & Scope
Research area (LetPub): Biochemistry & Molecular Biology
Editor-in-chief Zbigniew KmiećPublisher website
Editorial board by country: none in mainland China; most named Poland 15, United States 4, France 3, Italy 3, Japan 2 (31 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Protease and Inhibitor MechanismsBiochemistry, Genetics and Molecular Biology6.7%
- Sperm and Testicular FunctionMedicine6.3%
- Regulation of Appetite and ObesityNeuroscience5%
- Immune Response and InflammationImmunology and Microbiology4.8%
- Glycosylation and Glycoproteins ResearchBiochemistry, Genetics and Molecular Biology4.6%
- Growth Hormone and Insulin-like Growth FactorsMedicine4.6%
- Mesenchymal stem cell researchMedicine4.5%
- Cell Adhesion Molecules ResearchMedicine4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
| Minor | Cell Biology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
| Minor | Cell Biology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Biology Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
| Minor | Cell Biology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbasePublisher website
Other: Google Scholar, EBSCO, ProQuest, CNKI, OCLC, Crossref, Arianta, Biochemistry and Biophysics Citation Index, CNKI (China National Knowledge Index), Free Medical Journals (Geneva Foundation), Index Copernicus, Medical Journals Links, Polska Scientific Bibliography / Polindex, Polska Bibliografia Naukowa (PBN), Polish Medical Library (GBL), ROAD (Directory of Open Access Scholarly Resources), Urlichs' Periodicals Directory, WorldCat (OCLC), Biological Abstracts (WoS), Biosis Previews (WoS), SJR (Scimago Journal & Country Rank)
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.8LetPub ·
- Impact factor (publisher)
- 1.9Publisher website ·
- CiteScore 2026-06
- 4.1LetPub ·
- CiteScore (publisher)
- 4.1Publisher website ·
- SJR 2026-06
- 0.48LetPub ·
- SNIP 2026-06
- 0.48LetPub ·
- h-index
- 35LetPub ·
- h-index
- 46OpenAlex ·
- i10-index
- 465OpenAlex ·
- 2-year mean citedness
- 1.96OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 92.86%LetPub ·
Volume
- Articles per year
- 17LetPub ·
Articles by year OpenAlex count · 971 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 18 | 18 | 1 |
| 2025 | 20 | 20 | 34 |
| 2024 | 16 | 16 | 71 |
| 2023 | 19 | 19 | 105 |
| 2022 | 32 | 32 | 289 |
| 2021 | 31 | 31 | 308 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
69 daysMedian, submission to acceptance · P25–P75 38 days – 101 days
- Acceptance to online
- median 18 days (32 articles)
- Submission to online
- median 77 days
- Sample
- 35 articles with submission and acceptance dates (36 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to publication (journal-reported)
- about 20 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 1,200 | No | CC BY-NC-ND | |
| OpenAlex | EUR 370 | — | — | |
| LetPub | EUR 370 | No | — | |
| Publisher website | EUR 1,500 | — | — |
Other charges and waivers (author guidelines)
- Page charges
- EUR 1,500
- Submission fee
- EUR 1,500
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Keywords
- ≤ 10
- Reference style
- Vancouver
- Cover letter
- Required
Article types accepted10
- case reportItem type Guidelines / position paper Original article Research letter/brief communication Review Case report Study protocol Clinical vignette Editorial Technol…Length not stated
- clinical vignetteItem type Guidelines / position paper Original article Research letter/brief communication Review Case report Study protocol Clinical vignette Editorial Technol…Length not stated
- editorialItem type Guidelines / position paper Original article Research letter/brief communication Review Case report Study protocol Clinical vignette Editorial Technol…Length not stated
- guidelines / position paperItem type Guidelines / position paper Original article Research letter/brief communication Review Case report Study protocol Clinical vignette Editorial Technol…Length not stated
- letterItem type Guidelines / position paper Original article Research letter/brief communication Review Case report Study protocol Clinical vignette Editorial Technol…Length not stated
- original articleItem type Guidelines / position paper Original article Research letter/brief communication Review Case report Study protocol Clinical vignette Editorial Technol…Length not stated
- research letter/brief communicationItem type Guidelines / position paper Original article Research letter/brief communication Review Case report Study protocol Clinical vignette Editorial Technol…Length not stated
- reviewItem type Guidelines / position paper Original article Research letter/brief communication Review Case report Study protocol Clinical vignette Editorial Technol…Length not stated
- study protocolItem type Guidelines / position paper Original article Research letter/brief communication Review Case report Study protocol Clinical vignette Editorial Technol…Length not stated
- technology noteItem type Guidelines / position paper Original article Research letter/brief communication Review Case report Study protocol Clinical vignette Editorial Technol…Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review
- Authorship Author contributions
Please, describe the contribution of all co-authors to the final manuscript.
Source ↗Publisher website ·- Conflicts of interest Competing interests
Any possible conflicts of interest regarding the submitted article should be described for each author, or authors should declare they have no conflict of interest related to the submitted manuscript.
Source ↗Publisher website ·- Data availability Availability of data and materials
Please, indicate that original contributions presented in the study are included in the article (and as Supplementary Material, if applicable) and that further inquiries can be directed to the corresponding author.
Source ↗Publisher website ·- Publication ethics
Adheres to COPE principles Model summary
Via Medica strongly recommends journal editors to adhere to the principles of Committee on Publication Ethics (COPE), particularly to deal with acts of ethical misconduct.
Source ↗Publisher website ·- License & copyright Copyright Notice
By sending the manuscript with figures and charts the author (authors) declares (declare) it has been neither published nor submitted to the Editorial Board of any other journal (not including the abstracts 400 words or less). Moreover, it is assumed that the copyright for publishing and distribution of the submitted material (in all known now and developed in the future forms and fields of exploi…
Source ↗Publisher website ·- Open access Open Access Policy
Articles published online in Open Access are available under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) licence. This licence permits users to download and share the articles with others, provided that the authors and publisher are properly credited, but does not allow any modifications or commercial use. In justified cases, a CC BY licence may…
Source ↗Publisher website ·- Peer review
Follows ICMJE editorial recommendations Model summary
Journal follows editorial recommendations of International Committee of Medical Journal Editors (ICMJE) (available at http://www.icmje.org/recommendations/).
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Via Medica
- Country or region
- POLAND
- Language
- English
- Frequency
- Quarterly
- Founded
- 1984
- ISSN
- 0239-8508
- Electronic ISSN
- 1897-5631
- Latest issue on the website
- Volume 64, Issue 2 (2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗DOAJ
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Folia Histochemica et Cytobiologica
What CAS zone is Folia Histochemica et Cytobiologica in?
In the 2025 upgraded edition of the CAS Journal Ranking, Folia Histochemica et Cytobiologica is in Zone 4 of Biology, and in Zone 4 of the minor category Biochemistry & Molecular Biology / Cell Biology. In the 2026 Xinrui edition it is in Zone 3 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Folia Histochemica et Cytobiologica?
The latest impact factor listed by LetPub is 1.8; CiteScore 4.1, h-index 46.
How long does peer review take at Folia Histochemica et Cytobiologica?
Based on the dates recorded on 35 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 69 days (interquartile range 38–101 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Folia Histochemica et Cytobiologica?
According to the journal's author guidelines: Keywords: ≤ 10; Reference style: Vancouver; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Folia Histochemica et Cytobiologica based?
Of the 31 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Poland (15), United States (4) and France (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Folia Histochemica et Cytobiologica?
According to LetPub and DOAJ records, Folia Histochemica et Cytobiologica is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE and Embase; that list has not been checked against each database.
Is Folia Histochemica et Cytobiologica open access, and what is the APC?
Folia Histochemica et Cytobiologica is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .